Cargando…
Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy
With increasing incidence and mortality rates, cancer remains one of the most devastating global non-communicable diseases. Restricted dosages and decreased bioavailability, often results in lower therapeutic outcomes, triggering the development of resistance to conventionally used drug/gene therape...
Autores principales: | Moodley, Thashini, Singh, Moganavelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827023/ https://www.ncbi.nlm.nih.gov/pubmed/33430390 http://dx.doi.org/10.3390/pharmaceutics13010071 |
Ejemplares similares
-
Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy
por: Moodley, Thashini, et al.
Publicado: (2020) -
Polymeric Mesoporous Silica Nanoparticles for Enhanced Delivery of 5-Fluorouracil In Vitro
por: Moodley, Thashini, et al.
Publicado: (2019) -
Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
por: Colilla, Montserrat, et al.
Publicado: (2020) -
Supramolecular Nanomachines as Stimuli-Responsive Gatekeepers on Mesoporous Silica Nanoparticles for Antibiotic and Cancer Drug Delivery
por: Cheng, Chi-An, et al.
Publicado: (2019) -
Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook
por: Song, Yuanhui, et al.
Publicado: (2016)